The Lactic Acid Bacterium Pediococcus acidilactici Suppresses Autoimmune Encephalomyelitis by Inducing IL-10-Producing Regulatory T Cells.

These findings indicate the therapeutic potential of the oral administration of  a probiotic bacterium, Pediococcus acidilactici, for treating Multiple sclerosis
Enhanced by Zemanta

No comments: